Literature DB >> 6477127

Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis.

J G Forsberg.   

Abstract

Estrogens have long been thought to play a role in regulating the immune system. The difference in some types of immune responses between males and females is well-known, as is the pronounced thymic involution induced by exogenous estrogens. Estrogens stimulate some aspects of macrophage activity and, depending on dose and mitogen, inhibit or stimulate lymphocyte proliferative response in vitro. Another example is the estrogen effect on the delayed type hypersensitivity response. A broad review is given of such estrogen effects on lymphoid tissue and immune response. Most of the studies published so far are phenomenological. However, the recent description of estrogen receptors in the thymus and in some lymphocyte subpopulations, as well as a deeper understanding of regulating factors in the immune system, open the possibility of a more detailed understanding of the estrogen mechanism of interference. Estrogen effects in adults are reversible. After treating neonatal mice with the synthetic estrogen diethylstilbestrol (DES), disturbances are induced in lymphocyte populations and lymphocyte functions which are permanent and irreversible. Lymphocytes from adult, neonatally DES-treated female mice have a reduced mitogen response to ConA and LPS (T and B cell mitogen) and the delayed type hypersensitivity response is depressed. A detailed analysis demonstrated a decreased T helper cell population. The activity of Natural Killer cells is permanently reduced and this functional impairment is related to a decreased number of these cells, in turn determined at the bone marrow level. The same animals have an increased sensitivity to chemical carcinogens (methylcholanthrene) and they spontaneously develop epithelial changes in the uterine cervix which morphologically are similar to adenocarcinoma. The association between estrogen-associated malignancy and estrogen effects in lymphocyte functions deserves further study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477127     DOI: 10.1007/bf00346044

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  111 in total

1.  Actions of estrogens on blood and bone marrow.

Authors:  L E FOX
Journal:  J Pharm Sci       Date:  1961-05       Impact factor: 3.534

2.  Suppression of murine allogeneic cell interactions by sex hormones.

Authors:  C Pavia; P K Siiteri; J D Perlman; D P Stites
Journal:  J Reprod Immunol       Date:  1979 Jan-Feb       Impact factor: 4.054

3.  Autoradiographic study of the effect of estradiol and irradiation on nucleic acid metabolism of the thymus and lymph node of mice.

Authors:  J S Thompson; C D Severson; R W Reilly
Journal:  Radiat Res       Date:  1969-10       Impact factor: 2.841

4.  Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy.

Authors:  V Sridama; F Pacini; S L Yang; A Moawad; M Reilly; L J DeGroot
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

5.  Sensitivity to androgen. A possible factor in sex differences in the immune response.

Authors:  D A Cohn
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Specialized DNA polymerases in lymphoid cells.

Authors:  D Baltimore; A E Silverstone; P C Kung; T A Harrison; R P McCaffrey
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

7.  Effect of androgenic steroids on rat thymus and thymocytes in suspension.

Authors:  S Sasson; M Mayer
Journal:  J Steroid Biochem       Date:  1981-06       Impact factor: 4.292

8.  Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytes.

Authors:  T Kalland; O Strand; J G Forsberg
Journal:  J Natl Cancer Inst       Date:  1979-08       Impact factor: 13.506

9.  The effect of progesterone, oestradiol and HCG on cell-mediated immunity in pregnant mice.

Authors:  J Carter
Journal:  J Reprod Fertil       Date:  1976-01

10.  On the heterogeneity of murine natural killer cells.

Authors:  N Minato; L Reid; B R Bloom
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  7 in total

1.  Genetic mapping of loci controlling diethylstilbestrol-induced thymic atrophy in the Brown Norway rat.

Authors:  Karen A Gould; Tracy E Strecker; Kimberly K Hansen; Kimberly K Bynoté; Kelli A Peterson; James D Shull
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

2.  Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.

Authors:  Yani Lu; Sophia S Wang; Jane Sullivan-Halley; Ellen T Chang; Christina A Clarke; Katherine D Henderson; Huiyan Ma; Lei Duan; James V Lacey; Dennis Deapen; Leslie Bernstein
Journal:  Int J Cancer       Date:  2010-12-08       Impact factor: 7.396

3.  Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.

Authors:  Nilesh W Gaikwad; Li Yang; Dennis D Weisenburger; Julie Vose; Cheryl Beseler; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

4.  Relation of 8-ketotrichothecene and zearalenone analog structure to inhibition of mitogen-induced human lymphocyte blastogenesis.

Authors:  J H Forsell; J J Pestka
Journal:  Appl Environ Microbiol       Date:  1985-11       Impact factor: 4.792

5.  Exogenous hormone use, reproductive history and risk of adult myeloid leukaemia.

Authors:  J N Poynter; R Fonstad; C K Blair; M Roesler; J R Cerhan; B Hirsch; P Nguyen; J A Ross
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

6.  Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study.

Authors:  M Nørgaard; A H Poulsen; L Pedersen; H Gregersen; S Friis; M Ewertz; H E Johnsen; H T Sørensen
Journal:  Br J Cancer       Date:  2006-05-08       Impact factor: 7.640

7.  Suppression of B lymphopoiesis during normal pregnancy.

Authors:  K L Medina; G Smithson; P W Kincade
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.